Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

In vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse.

Amoasii L, Li H, Zhang Y, Min YL, Sanchez-Ortiz E, Shelton JM, Long C, Mireault AA, Bhattacharyya S, McAnally JR, Bassel-Duby R, Olson EN.

Nat Commun. 2019 Oct 4;10(1):4537. doi: 10.1038/s41467-019-12335-x.

2.

CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells.

Min YL, Li H, Rodriguez-Caycedo C, Mireault AA, Huang J, Shelton JM, McAnally JR, Amoasii L, Mammen PPA, Bassel-Duby R, Olson EN.

Sci Adv. 2019 Mar 6;5(3):eaav4324. doi: 10.1126/sciadv.aav4324. eCollection 2019 Mar.

3.

MOXI Is a Mitochondrial Micropeptide That Enhances Fatty Acid β-Oxidation.

Makarewich CA, Baskin KK, Munir AZ, Bezprozvannaya S, Sharma G, Khemtong C, Shah AM, McAnally JR, Malloy CR, Szweda LI, Bassel-Duby R, Olson EN.

Cell Rep. 2018 Jun 26;23(13):3701-3709. doi: 10.1016/j.celrep.2018.05.058.

4.

Fusogenic micropeptide Myomixer is essential for satellite cell fusion and muscle regeneration.

Bi P, McAnally JR, Shelton JM, Sánchez-Ortiz E, Bassel-Duby R, Olson EN.

Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):3864-3869. doi: 10.1073/pnas.1800052115. Epub 2018 Mar 26.

5.

Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy.

Amoasii L, Long C, Li H, Mireault AA, Shelton JM, Sanchez-Ortiz E, McAnally JR, Bhattacharyya S, Schmidt F, Grimm D, Hauschka SD, Bassel-Duby R, Olson EN.

Sci Transl Med. 2017 Nov 29;9(418). pii: eaan8081. doi: 10.1126/scitranslmed.aan8081. Erratum in: Sci Transl Med. 2018 Jan 24;10 (425):.

6.

Deficiency in Kelch protein Klhl31 causes congenital myopathy in mice.

Papizan JB, Garry GA, Brezprozvannaya S, McAnally JR, Bassel-Duby R, Liu N, Olson EN.

J Clin Invest. 2017 Oct 2;127(10):3730-3740. doi: 10.1172/JCI93445. Epub 2017 Sep 5.

7.

CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice.

Zhang Y, Long C, Li H, McAnally JR, Baskin KK, Shelton JM, Bassel-Duby R, Olson EN.

Sci Adv. 2017 Apr 12;3(4):e1602814. doi: 10.1126/sciadv.1602814. eCollection 2017 Apr.

8.

Control of muscle formation by the fusogenic micropeptide myomixer.

Bi P, Ramirez-Martinez A, Li H, Cannavino J, McAnally JR, Shelton JM, Sánchez-Ortiz E, Bassel-Duby R, Olson EN.

Science. 2017 Apr 21;356(6335):323-327. doi: 10.1126/science.aam9361. Epub 2017 Apr 6.

9.

Transcription of the non-coding RNA upperhand controls Hand2 expression and heart development.

Anderson KM, Anderson DM, McAnally JR, Shelton JM, Bassel-Duby R, Olson EN.

Nature. 2016 Nov 17;539(7629):433-436. doi: 10.1038/nature20128. Epub 2016 Oct 26.

10.

Severe muscle wasting and denervation in mice lacking the RNA-binding protein ZFP106.

Anderson DM, Cannavino J, Li H, Anderson KM, Nelson BR, McAnally J, Bezprozvannaya S, Liu Y, Lin W, Liu N, Bassel-Duby R, Olson EN.

Proc Natl Acad Sci U S A. 2016 Aug 2;113(31):E4494-503. doi: 10.1073/pnas.1608423113. Epub 2016 Jul 14.

11.

A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle.

Nelson BR, Makarewich CA, Anderson DM, Winders BR, Troupes CD, Wu F, Reese AL, McAnally JR, Chen X, Kavalali ET, Cannon SC, Houser SR, Bassel-Duby R, Olson EN.

Science. 2016 Jan 15;351(6270):271-5. doi: 10.1126/science.aad4076.

12.

Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy.

Long C, Amoasii L, Mireault AA, McAnally JR, Li H, Sanchez-Ortiz E, Bhattacharyya S, Shelton JM, Bassel-Duby R, Olson EN.

Science. 2016 Jan 22;351(6271):400-3. doi: 10.1126/science.aad5725. Epub 2015 Dec 31.

13.

A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9.

Carroll KJ, Makarewich CA, McAnally J, Anderson DM, Zentilin L, Liu N, Giacca M, Bassel-Duby R, Olson EN.

Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):338-43. doi: 10.1073/pnas.1523918113. Epub 2015 Dec 30.

14.

Severe myopathy in mice lacking the MEF2/SRF-dependent gene leiomodin-3.

Cenik BK, Garg A, McAnally JR, Shelton JM, Richardson JA, Bassel-Duby R, Olson EN, Liu N.

J Clin Invest. 2015 Apr;125(4):1569-78. doi: 10.1172/JCI80115. Epub 2015 Mar 16.

15.

A micropeptide encoded by a putative long noncoding RNA regulates muscle performance.

Anderson DM, Anderson KM, Chang CL, Makarewich CA, Nelson BR, McAnally JR, Kasaragod P, Shelton JM, Liou J, Bassel-Duby R, Olson EN.

Cell. 2015 Feb 12;160(4):595-606. doi: 10.1016/j.cell.2015.01.009. Epub 2015 Jan 29.

16.

Induction of diverse cardiac cell types by reprogramming fibroblasts with cardiac transcription factors.

Nam YJ, Lubczyk C, Bhakta M, Zang T, Fernandez-Perez A, McAnally J, Bassel-Duby R, Olson EN, Munshi NV.

Development. 2014 Nov;141(22):4267-78. doi: 10.1242/dev.114025. Epub 2014 Oct 24.

17.

Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA.

Long C, McAnally JR, Shelton JM, Mireault AA, Bassel-Duby R, Olson EN.

Science. 2014 Sep 5;345(6201):1184-1188. doi: 10.1126/science.1254445. Epub 2014 Aug 14.

18.

Relationship of plasma metal ions and clinical and imaging findings in patients with ASR XL metal-on-metal total hip replacements.

Chang EY, McAnally JL, Van Horne JR, Van Horne JG, Wolfson T, Gamst A, Chung CB.

J Bone Joint Surg Am. 2013 Nov 20;95(22):2015-20. doi: 10.2106/JBJS.L.01481.

PMID:
24257659
19.

Hippo pathway effector Yap promotes cardiac regeneration.

Xin M, Kim Y, Sutherland LB, Murakami M, Qi X, McAnally J, Porrello ER, Mahmoud AI, Tan W, Shelton JM, Richardson JA, Sadek HA, Bassel-Duby R, Olson EN.

Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13839-44. doi: 10.1073/pnas.1313192110. Epub 2013 Aug 5.

20.

Skeletal muscle-specific T-tubule protein STAC3 mediates voltage-induced Ca2+ release and contractility.

Nelson BR, Wu F, Liu Y, Anderson DM, McAnally J, Lin W, Cannon SC, Bassel-Duby R, Olson EN.

Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11881-6. doi: 10.1073/pnas.1310571110. Epub 2013 Jul 1.

21.

C/EBP transcription factors mediate epicardial activation during heart development and injury.

Huang GN, Thatcher JE, McAnally J, Kong Y, Qi X, Tan W, DiMaio JM, Amatruda JF, Gerard RD, Hill JA, Bassel-Duby R, Olson EN.

Science. 2012 Dec 21;338(6114):1599-603. doi: 10.1126/science.1229765. Epub 2012 Nov 15.

22.

Metal-on-metal total hip arthroplasty: do symptoms correlate with MR imaging findings?

Chang EY, McAnally JL, Van Horne JR, Statum S, Wolfson T, Gamst A, Chung CB.

Radiology. 2012 Dec;265(3):848-57. doi: 10.1148/radiol.12120852. Epub 2012 Oct 9.

PMID:
23047842
23.

Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size.

Xin M, Kim Y, Sutherland LB, Qi X, McAnally J, Schwartz RJ, Richardson JA, Bassel-Duby R, Olson EN.

Sci Signal. 2011 Oct 25;4(196):ra70. doi: 10.1126/scisignal.2002278.

24.

EHR adoption supported by tnREC.

McAnally J.

Tenn Med. 2011 Feb;104(2):31-2. No abstract available.

PMID:
21387895
25.

Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases.

Moresi V, Williams AH, Meadows E, Flynn JM, Potthoff MJ, McAnally J, Shelton JM, Backs J, Klein WH, Richardson JA, Bassel-Duby R, Olson EN.

Cell. 2010 Oct 1;143(1):35-45. doi: 10.1016/j.cell.2010.09.004.

26.

Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486.

Small EM, O'Rourke JR, Moresi V, Sutherland LB, McAnally J, Gerard RD, Richardson JA, Olson EN.

Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4218-23. doi: 10.1073/pnas.1000300107. Epub 2010 Feb 8.

27.

Case acceptance: no random acts allowed.

McAnally J.

Dent Today. 2009 Dec;28(12):10, 12.

PMID:
20055038
28.

MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice.

Williams AH, Valdez G, Moresi V, Qi X, McAnally J, Elliott JL, Bassel-Duby R, Sanes JR, Olson EN.

Science. 2009 Dec 11;326(5959):1549-54. doi: 10.1126/science.1181046.

29.

The gamma isoform of CaM kinase II controls mouse egg activation by regulating cell cycle resumption.

Backs J, Stein P, Backs T, Duncan FE, Grueter CE, McAnally J, Qi X, Schultz RM, Olson EN.

Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):81-6. doi: 10.1073/pnas.0912658106. Epub 2009 Dec 4.

30.

MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury.

Xin M, Small EM, Sutherland LB, Qi X, McAnally J, Plato CF, Richardson JA, Bassel-Duby R, Olson EN.

Genes Dev. 2009 Sep 15;23(18):2166-78. doi: 10.1101/gad.1842409. Epub 2009 Aug 31.

31.

Cx30.2 enhancer analysis identifies Gata4 as a novel regulator of atrioventricular delay.

Munshi NV, McAnally J, Bezprozvannaya S, Berry JM, Richardson JA, Hill JA, Olson EN.

Development. 2009 Aug;136(15):2665-74. doi: 10.1242/dev.038562.

32.

Tension hemomediastinum secondary to blunt chest trauma in a patient with an anomalous manubrial-sternal junction.

Marinaro J, Zwehl-Burke S, McAnally J, Crandall C, Demarest G.

J Trauma. 2009 May;66(5):1489-91. doi: 10.1097/TA.0b013e31802e749d. No abstract available.

PMID:
19065120
33.

New thoughts on the origin of Pellegrini-Stieda: the association of PCL injury and medial femoral epicondylar periosteal stripping.

McAnally JL, Southam SL, Mlady GW.

Skeletal Radiol. 2009 Feb;38(2):193-8. doi: 10.1007/s00256-008-0604-7. Epub 2008 Nov 5.

PMID:
18985339
34.

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis.

Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN.

Dev Cell. 2008 Aug;15(2):261-71. doi: 10.1016/j.devcel.2008.07.002.

35.

Medial collateral ligament tear entrapped within a proximal tibial physeal separation: imaging findings and operative reduction.

McAnally JL, Eberhardt SC, Mlady GW, Fitzpatrick J, Bosch P.

Skeletal Radiol. 2008 Oct;37(10):943-6. doi: 10.1007/s00256-008-0521-9. Epub 2008 Aug 9.

PMID:
18690430
36.

Summary of electronic medical record (EMR) vendor review.

McAnally J.

Tenn Med. 2008 Jul;101(7):34-5. No abstract available.

PMID:
18649627
37.

MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function.

Barbosa AC, Kim MS, Ertunc M, Adachi M, Nelson ED, McAnally J, Richardson JA, Kavalali ET, Monteggia LM, Bassel-Duby R, Olson EN.

Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9391-6. doi: 10.1073/pnas.0802679105. Epub 2008 Jul 1.

38.

Protein kinase D1 stimulates MEF2 activity in skeletal muscle and enhances muscle performance.

Kim MS, Fielitz J, McAnally J, Shelton JM, Lemon DD, McKinsey TA, Richardson JA, Bassel-Duby R, Olson EN.

Mol Cell Biol. 2008 Jun;28(11):3600-9. doi: 10.1128/MCB.00189-08. Epub 2008 Mar 31.

39.

An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133.

Liu N, Williams AH, Kim Y, McAnally J, Bezprozvannaya S, Sutherland LB, Richardson JA, Bassel-Duby R, Olson EN.

Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20844-9. Epub 2007 Dec 19.

40.

Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy.

Zhao G, Jeoung NH, Burgess SC, Rosaaen-Stowe KA, Inagaki T, Latif S, Shelton JM, McAnally J, Bassel-Duby R, Harris RA, Richardson JA, Kliewer SA.

Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H936-43. Epub 2007 Dec 14.

41.

The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice.

Kim Y, Phan D, van Rooij E, Wang DZ, McAnally J, Qi X, Richardson JA, Hill JA, Bassel-Duby R, Olson EN.

J Clin Invest. 2008 Jan;118(1):124-32.

42.

Regulation of skeletal muscle sarcomere integrity and postnatal muscle function by Mef2c.

Potthoff MJ, Arnold MA, McAnally J, Richardson JA, Bassel-Duby R, Olson EN.

Mol Cell Biol. 2007 Dec;27(23):8143-51. Epub 2007 Sep 17.

43.

Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers.

Potthoff MJ, Wu H, Arnold MA, Shelton JM, Backs J, McAnally J, Richardson JA, Bassel-Duby R, Olson EN.

J Clin Invest. 2007 Sep;117(9):2459-67.

44.

Modulation of adverse cardiac remodeling by STARS, a mediator of MEF2 signaling and SRF activity.

Kuwahara K, Teg Pipes GC, McAnally J, Richardson JA, Hill JA, Bassel-Duby R, Olson EN.

J Clin Invest. 2007 May;117(5):1324-34. Epub 2007 Apr 5.

45.

Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.

McAnally JA, Gupta J, Sodhani S, Bravo L, Mo H.

Exp Biol Med (Maywood). 2007 Apr;232(4):523-31.

PMID:
17392488
46.

MEF2C transcription factor controls chondrocyte hypertrophy and bone development.

Arnold MA, Kim Y, Czubryt MP, Phan D, McAnally J, Qi X, Shelton JM, Richardson JA, Bassel-Duby R, Olson EN.

Dev Cell. 2007 Mar;12(3):377-89.

47.

A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.

van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN.

Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18255-60. Epub 2006 Nov 15.

48.

Regulation of HDAC9 gene expression by MEF2 establishes a negative-feedback loop in the transcriptional circuitry of muscle differentiation.

Haberland M, Arnold MA, McAnally J, Phan D, Kim Y, Olson EN.

Mol Cell Biol. 2007 Jan;27(2):518-25. Epub 2006 Nov 13.

49.

TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling.

Kuwahara K, Wang Y, McAnally J, Richardson JA, Bassel-Duby R, Hill JA, Olson EN.

J Clin Invest. 2006 Dec;116(12):3114-26. Epub 2006 Nov 9.

50.

Myocardin is a direct transcriptional target of Mef2, Tead and Foxo proteins during cardiovascular development.

Creemers EE, Sutherland LB, McAnally J, Richardson JA, Olson EN.

Development. 2006 Nov;133(21):4245-56. Epub 2006 Oct 4.

Supplemental Content

Loading ...
Support Center